Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

2 results about "Carboxymethylcellulose Sodium" patented technology

A cellulose derivative which is a beta-(1,4)-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.

Copper oxide/carboxymethyl cellulose gel modified composite film, and making method and use thereof

InactiveCN106943883AEfficient separationSimple construction methodSemi-permeable membranesNon-miscible liquid separationCarboxymethyl celluloseComposite film
The invention provides a copper oxide/carboxymethyl cellulose gel modified composite film, and a making method and a use thereof. The making method comprises the following steps: washing and drying a copper net; cutting the dried copper net, carrying out high temperature calcination on the cut copper net in a tubular furnace, naturally cooling the calcined copper net to room temperature, and taking out the naturally cooled copper net; impregnating the calcined copper net in a carboxymethylcellulose sodium solution for a period of time, taking out the impregnated copper net, and impregnating the copper net in a Fe<3+> solution; and taking out the copper net a period of time later, placing the impregnating copper net in an oven, drying the copper net at a certain temperature for a period of time, continuously repeating the above impregnating operation to make the copper oxide/carboxymethyl cellulose gel modified composite film, and preserving the copper oxide/carboxymethyl cellulose gel modified composite film in water. The CuO-CMC modified composite film is produced through the method for high temperature calcination of the copper net and coating of the surface with an organic layer. The making method has the advantages of simplicity in operation, obvious separation effect and high practical values.
Owner:JIANGSU UNIV

Anticancer medicine composition of taxane and its synergist

PendingCN101006982AOrganic active ingredientsSolution deliveryPhosphoric Acid EstersCellulose
Disclosed is a slow release injection agent of anticancer composition containing taxone and synergistic agent, which comprises slow release microspheres and dissolvent, wherein the slow release microballoons comprise anti-cancer active constituents and slow release auxiliary materials, the dissolvent being conventional dissolvent or specific dissolvent containing suspension adjuvant. The viscosity of the suspension adjuvant is 100-3000cp (at 20-30 deg C), and is selected from sodium carboxymethylcellulose, the anticancer active constituents include taxone and / or taxone synergistic agent selected from antimitotic drugs, alkylating agent and / or antimetabolites, the slow release auxiliary materials are selected from polyphosphate ester copolymers such as p(LAEG-EOP), p(DAPG-EOP), copolymer of polyphosphate ester with polylactic acid, Polifeprosan, di-aliphatic acid and sebacylic acid, copolymer or blend of poly(erucic aciddipolymer-sebacylic acid) or poly(fumaric acid-sebacylic acid). The anticancer composition can also be prepared into slow release implanting agent, for injection or placement in or around tumor with a period of effective concentration maintenance over 40 days, as well as the treatment effect of appreciably lowering general reaction of the drugs, and improving the treatment effect of the non-operative treatment methods such as chemotherapy.
Owner:JINAN KANGQUAN PHARMA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products